[EN] MODULATORS OF CRTH2 RECEPTOR ACTIVITY FOR THE TREATMENT OF PROSTAGLANDIN D2 MEDIATED DISEASES<br/>[FR] NOUVEAUX COMPOSES
申请人:ASTRAZENECA AB
公开号:WO2006037982A3
公开(公告)日:2006-08-17
Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
申请人:Bonnert Victor Roger
公开号:US20070249686A1
公开(公告)日:2007-10-25
The invention relates to substituted acids as useful pharmaceutical compounds for treating respiratory disorders as asthma, pharmaceutical compositions containing them, and processes for their preparation.